Medline Inc. (MDLN) Cash Flow Statement
Medline Inc. (MDLN) generated $2.0B of operating cash flow over the twelve months to 2026-06-30, spent $446.0M on capital expenditure and had free cash flow of $1.5B, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MDLNMedline Inc.Follow MDLN — free
—
Price chart with a free account
- Market cap
- 44.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Operating cash flow | 1.69 | 1.77 | 1.74 | 1.99 | |
| Capital expenditure | 0.28 | 0.35 | 0.45 | -0.45 | |
| Free cash flow | 1.41 | 1.42 | 1.30 | 1.55 | |
| Share repurchases | 0.00 | 0.02 | 0.03 | — | |
| Stock-based compensation | 0.08 | 0.06 | 0.08 | — |
USD billions · SEC XBRL
Medline Inc. — questions
- What is Medline Inc.'s operating cash flow?
- $2.0B over the twelve months to 2026-06-30.
- How much does Medline Inc. spend on capital expenditure?
- $446.0M over the twelve months to 2026-06-30.
- What is Medline Inc.'s free cash flow?
- $1.5B over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Medline Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.